Recently, myeloid-specific HDAC inhibition using an esterase-sensitive motif (ESM) technology has been shown to impair maturation and activation of peritoneal macrophages with limited efficacy on atherosclerosis [83]. This evidence concerns the gene HDAC9 and atherosclerosis.